News

Guska: New CEO, Shift in Research Focus, and Partnership with Marvik

Guska: New CEO, Shift in Research Focus, and Partnership with Marvik

In April 2025, Nicolás Tambucho joined Guska as CEO at the invitation of the startup’s founders, Gonzalo Moratorio and Pilar Moreno. Backed by LAB+, Guska develops oncolytic viruses that selectively attack tumor cells without harming healthy ones. Before taking on this new role, Tambucho served as CEO and COO (Chief Operating Officer) of RADBIO,...

read more
Meeting with Veterinarians on Pilot Tick Vaccination Plan

Meeting with Veterinarians on Pilot Tick Vaccination Plan

Members of the National Academy of Veterinary Medicine, the Veterinary Medicine Society, the School of Veterinary Medicine at Udelar, and the Ministry of Livestock, Agriculture and Fisheries (MGAP) visited the Institut Pasteur de Montevideo for a knowledge-sharing session on the tick vaccine being developed by the startup Scaffold Biotech and the...

read more

Read the second edition of our newsletter here.

(It’s in Spanish, but there’s a translation option at the top right of the menu)

Read the first edition here.

LAB+ in the Media:

Local

Radio Sarandí – Interview with Matías Machado about Scaffold Biotech’s cattle tick vaccine

El País – The five key features of the Uruguayan vaccine that could change the fight against ticks

Radio Sarandí – Carlos Batthyány talks about Lab+, the vaccine developed by Scaffold Biotech, and the drug from Eolo Pharma

InfoNegocios – A Uruguayan startup dedicated to early cancer diagnosis adds a former dLocal member as CEO

Forbes Uruguay – Interview with Carlos Batthyány about LAB+ and the Institut Pasteur de Montevideo

Búsqueda – International call for startups, interview with Carlos Batthyány and Paul Elberse

En Perspectiva – Agustín Correa and Matías Machado, from Scaffold Biotech: Uruguayan company works with protein engineering to reach a ‘new frontier in vaccination’

Modo País (Channel 5) – Guska, created by Pilar Moreno and Gonzalo Moratorio

En Perspectiva – Felipe Trajtenberg, from LoCBio: reprogramming bacteria to treat colorectal cancer

La Diaria – What do the first four start-ups of the LAB+ seek to develop?

Telemundo  (Channel 12) – Scaffold Biotech: more efficient vaccines for animals

En Perspectiva – Director of the Institut Pasteur de Montevideo talks about the LAB+ iniciative and Gonzalo Moratorio explains the science behind the start-up Guska

Subrayado (Channel 10) – LAB+ closed its first financing cycle

Radio Carve – Director of the Institut Pasteur de Montevideo talks about LAB+

La Diaria – Conversations with the first four biotech start-ups funded by LAB+

El País (Business) – Institut Pasteur de Montevideo presented its first four start-ups

Uruguay XXI – Institut Pasteur de Montevideo presented its first four start-ups

Telenoche (Channel 4) – Juan Pablo Tosar talks about the start-up B4-RNA

Ambito – The Institut Pasteur will invest US$25M in Uruguayan start-ups

El Observador – Four start-ups from the Institut Pasteur de Montevideo obtained financing for US$ 5 million: which are they?

Telenoche (Channel 4) – Institut Pasteur de Montevideo presented its LAB+ Company Builder initiative

Montevideo Portal – The Institut Pasteur de Montevideo presents a program to support scientific-technological companies